JNJ stock price today: Johnson & Johnson shares hold steady as drug news and a Bayer lawsuit collide
Johnson & Johnson shares slipped 0.1% to $245.6 Tuesday, lagging a 0.8% S&P 500 gain, as the stock traded ex-dividend and investors weighed new oncology updates and legal risk. Bayer sued the company over Erleada marketing claims, seeking an injunction and damages in Manhattan federal court. The European Commission approved new subcutaneous dosing for Rybrevant.